Keywords:
tizimli sklerodermiya, interleykin-6, Rodnan teri sh- kalasi, C-reaktiv oqsil.References
1. Abdurakhmanova NM. Modern methods of treat- ment of patients with ankylosing spondylitis. Int J Adv Sci Res.2022;2(11):112-8.
2. Bossuyt X, De Langhe E, Borghi MO, Meroni PL. Under- standing and interpreting antinuclear antibody tests in sys- temic rheumatic diseases. Nat Rev Rheumatol.2020;16(12).
3. De Carvalho JF, Shoenfeld Y. Systemic Sclerosis Sine Scleroderma After Silicone Breast Implants. J Clin Rheuma- tol.2022;28(4).
4. De Luca G, Bombace S, Monti L. Heart Involvement in Sys- temic Sclerosis: the Role of Magnetic Resonance Imaging. Clin Rev Allergy Immunol.2023;64(3)
5. Istamovich ZS, Sadullayevich AK, Mirza-Bakhtiyarkha- novna AN. The Significance of Autoantibodies in the Patho- genesis of Systemic Sclerosis (Literature Review). J Biomed Pract.2023;8(2).
6. Khalmetova FI, Akhmedov KS, Turayev IA, & Zaripov SI. Рeaктив aртритни дaвoлaшдa зaмoнaвий патогенетик ёндaшувлaр. Вестн ТМА.2024;3:63-65.
7. Lechartier B, Humbert M. Pulmonary arterial hyperten- sion in systemic sclerosis. Presse Med.2021;50(1).
8. Lee A. Fibrillarin antibodies in systemic sclerosis. Arch Rheumatol.2021;37(2).
9. Turaev SZI, Rakhimov S. Assessment of the quality of life in patients with chronic kidney disease in the practice of he- modialysis. J Modern Educ Achievements.2023;6(6):103-9.
10. Zaripov SI, Raximova MB. Quality of Life in Patients with Terminal Stage Renal Disease Receiving Programmed Hemodi- alysis. Innov Modern Educ Syst.2023;3(26): 228-9.
